Andrew R. Field

Andrew R. Field

Auto-generated profile, based on publicly available information

Andrew R. Field

Regel Therapeutics, Inc., Cambridge, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Cell
Verified
Journal Article
Closed access
IFIan T. Fiddes
Ian T. Fiddes
GLGerrald A. Lodewijk
Gerrald A. Lodewijk
MMMeghan Mooring
Meghan Mooring
CBColleen M. Bosworth
Colleen M. Bosworth
AEAdam Ewing
Adam Ewing
DHDavid Haussler
David Haussler

1 February 2019 in Stem Cell Reports
Verified
Journal Article
Open access
AFAndrew R. Field
Andrew R. Field
FJFrank MJ Jacobs
Frank MJ Jacobs
IFIan T. Fiddes
Ian T. Fiddes
APAlex P.R. Phillips
Alex P.R. Phillips
ARAndrea M. Reyes-Ortiz
Andrea M. Reyes-Ortiz
DHDavid Haussler
David Haussler
The cerebral cortex has expanded in size and complexity in primates, yet the molecular innovations that enabled primate-specific brain attributes remain obscure. We generated cerebral cortex organoids from human, chimpanzee, orangutan, and rhesus pluripotent stem cells and sequenced their transcriptomes at weekly time points for comparative analysis. We used transcript structure and expression conservation to discover gene regulatory long non-coding RNAs (lncRNAs). Of 2,975 human, multi-exonic lncRNAs, 2,472 were structurally conserved in at least one other species and 920 were conserved in all. Three hundred eighty-six human lncRNAs were transiently expressed (TrEx) and many were also TrEx in great apes (46%) and rhesus (31%). Many TrEx lncRNAs are expressed in specific cell types by single-cell RNA sequencing. Four TrEx lncRNAs selected based on cell-type specificity, gene structure, and expression pattern conservation were ectopically expressed in HEK293 cells by CRISPRa. All induced trans gene expression changes were consistent with neural gene regulatory activity.

9 June 2022 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
HVHanneke Vlaming
Hanneke Vlaming
CMClaudia A. Mimoso
Claudia A. Mimoso
AFAndrew R. Field
Andrew R. Field
BMBenjamin J. E. Martin
Benjamin J. E. Martin
KAKaren Adelman
Karen Adelman

30 November 2022 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
JLJennifer M Luppino
Jennifer M Luppino
AFAndrew Field
Andrew Field
SNSon C Nguyen
Son C Nguyen
DPDaniel S Park
Daniel S Park
PSParisha P Shah
Parisha P Shah
EJEric F Joyce
Eric F Joyce
The relationship between cohesin-mediated chromatin looping and gene expression remains unclear. NIPBL and WAPL are two opposing regulators of cohesin activity; depletion of either is associated with changes in both chromatin folding and transcription across a wide range of cell types. However, a direct comparison of their individual and combined effects on gene expression in the same cell type is lacking. We find that NIPBL or WAPL depletion in human HCT116 cells each alter the expression of ~2,000 genes, with only ~30% of the genes shared between the conditions. We find that clusters of differentially expressed genes within the same topologically associated domain (TAD) show coordinated misexpression, suggesting some genomic domains are especially sensitive to both more or less cohesin. Finally, co-depletion of NIPBL and WAPL restores the majority of gene misexpression as compared to either knockdown alone. A similar set of NIPBL-sensitive genes are rescued following CTCF co-depletion. Together, this indicates that altered transcription due to reduced cohesin activity can be functionally offset by removal of either its negative regulator (WAPL) or the physical barriers (CTCF) that restrict loop-extrusion events.

28 September 2010 in Biochemistry
Verified
Journal Article
Closed access
AFAndrew Field
Andrew Field
BHByron Hetrick
Byron Hetrick
MMMerrill Mathew
Merrill Mathew
SJSimpson Joseph
Simpson Joseph

1 June 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
HVHanneke Vlaming
Hanneke Vlaming
CMClaudia A. Mimoso
Claudia A. Mimoso
BMBenjamin Je Martin
Benjamin Je Martin
AFAndrew R Field
Andrew R Field
KAKaren Adelman
Karen Adelman
Organismal growth and development rely on RNA Polymerase II (RNAPII) synthesizing the appropriate repertoire of messenger RNAs (mRNAs) from protein-coding genes. Productive elongation of full-length transcripts is essential for mRNA function, however what determines whether an engaged RNAPII molecule will terminate prematurely or transcribe processively remains poorly understood. Notably, despite a common process for transcription initiation across RNAPII-synthesized RNAs 1 , RNAPII is highly susceptible to termination when transcribing non-coding RNAs such as upstream antisense RNAs (uaRNAs) and enhancers RNAs (eRNAs) 2 , suggesting that differences arise during RNAPII elongation. To investigate the impact of transcribed sequence on elongation potential, we developed a method to screen the effects of thousands of IN tegrated S equences on E xpression of R NA and T ranslation using high-throughput sequencing (INSERT-seq). We found that higher AT content in uaRNAs and eRNAs, rather than specific sequence motifs, underlies the propensity for RNAPII termination on these transcripts. Further, we demonstrate that 5’ splice sites exert both splicing-dependent and autonomous, splicing-independent stimulation of transcription, even in the absence of polyadenylation signals. Together, our results reveal a potent role for transcribed sequence in dictating gene output at mRNA and non-coding RNA loci, and demonstrate the power of INSERT-seq towards illuminating these contributions.